Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00088153 · ClinicalTrials.gov registry record · Phase 2
Effects of Anorexia Nervosa on Bone Mass in Adolescents
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00088153: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT00088153 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00088153, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study is to determine the effects of anorexia nervosa on bone mass and hormone levels in adolescents. Whether administration of estrogen, a normal hormone present during puberty, can help maintain bone development in girls with anorexia nervosa will be determined.
Interventions
- OTHER Placebo
- DRUG Physiologic Estrogen/progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2003-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00088153
The ClinicalTrials.gov registry entry for NCT00088153 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00088153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00088153 about?
NCT00088153 is a clinical study titled "Effects of Anorexia Nervosa on Bone Mass in Adolescents". This study is to determine the effects of anorexia nervosa on bone mass and hormone levels in adolescents. Whether administration of estrogen, a normal hormone present during puberty, can help maintain bone development in girls with anorexia nervosa will be determined.
What is the current status of trial NCT00088153?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2003-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00088153?
The interventions under investigation include: Placebo (OTHER), Physiologic Estrogen/progesterone (DRUG).
Who is sponsoring clinical trial NCT00088153?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.